Similar articles

• Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial.

  Parker C, Waters R, Leighton C, Hancock J, Sutton R, Moorman AV, Ancliff P, Morgan M, Masurekar A, Goulden N, Green N, Révész T, Darbyshire P, Love S, Saha V. Parker C, et al. Lancet. 2010 Dec 11;376(9757):2009-17. doi: 10.1016/S0140-6736(10)62002-8. Epub 2010 Dec 3. Lancet. 2010. PMID: 21131038 Free PMC article. Clinical Trial.
• Idarubicin in acute leukaemia. GIMEMA Group.

  Mandelli F, Annino L, Avvisati G, Giona F, Meloni G, Petti MC, Testi AM, Carella AM, Caronia F, Carotenuto M, et al. Mandelli F, et al. Bone Marrow Transplant. 1989 Dec;4 Suppl 3:49-52. Bone Marrow Transplant. 1989. PMID: 2697401 Clinical Trial. No abstract available.
• Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: a report from the Children's Cancer Group.

  Feig SA, Ames MM, Sather HN, Steinherz L, Reid JM, Trigg M, Pendergrass TW, Warkentin P, Gerber M, Leonard M, Bleyer WA, Harris RE. Feig SA, et al. Med Pediatr Oncol. 1996 Dec;27(6):505-14. doi: 10.1002/(SICI)1096-911X(199612)27:6<505::AID-MPO1>3.0.CO;2-P. Med Pediatr Oncol. 1996. PMID: 8888809 Clinical Trial.
• [Treatment of acute and chronic leukemias].

  Mandelli F, Montefusco E. Mandelli F, et al. Recenti Prog Med. 1999 Nov;90(11):605-12. Recenti Prog Med. 1999. PMID: 10608151 Review. Italian.
• The role of anthracyclines in adult acute lymphoblastic leukaemia.

  Bassan R, Lerede T, Rambaldi A, Di Bona E, Rossi G, Pogliani E, Lambertenghi-Deliliers G, Porcellini A, Fabris P, Barbui T. Bassan R, et al. Leukemia. 1996 Jun;10 Suppl 2:s58-61. Leukemia. 1996. PMID: 8649053 Review.